Health Catalyst Inc (HCAT)
6.46
-0.19
(-2.86%)
USD |
NASDAQ |
May 09, 14:43
Health Catalyst Research and Development Expense (Quarterly): 20.29M for Dec. 31, 2023
Research and Development Expense (Quarterly) Chart
Historical Research and Development Expense (Quarterly) Data
| Date | Value |
|---|---|
| December 31, 2023 | 20.29M |
| September 30, 2023 | 17.67M |
| June 30, 2023 | 17.59M |
| March 31, 2023 | 17.08M |
| December 31, 2022 | 19.61M |
| September 30, 2022 | 20.77M |
| June 30, 2022 | 18.15M |
| March 31, 2022 | 17.15M |
| December 31, 2021 | 17.48M |
| September 30, 2021 | 16.38M |
| June 30, 2021 | 14.52M |
| March 31, 2021 | 14.34M |
| Date | Value |
|---|---|
| December 31, 2020 | 14.98M |
| September 30, 2020 | 13.39M |
| June 30, 2020 | 12.06M |
| March 31, 2020 | 13.09M |
| December 31, 2019 | 13.04M |
| September 30, 2019 | 13.48M |
| June 30, 2019 | 9.71M |
| March 31, 2019 | 10.02M |
| December 31, 2018 | 10.56M |
| September 30, 2018 | 10.84M |
| June 30, 2018 | 8.487M |
| March 31, 2018 | 8.705M |
R&D Expense Definition
R&D expense is a line item from many companies' income statements.
Research and Development Expense (Quarterly) Range, Past 5 Years
9.71M
Minimum
Jun 2019
20.77M
Maximum
Sep 2022
15.83M
Average
16.38M
Median
Sep 2021